Arcutis Biotherapeutics Inc. (ARQT)
15.00
-0.64 (-4.09%)
At close: Apr 01, 2025, 3:59 PM
15.17
1.11%
After-hours: Apr 01, 2025, 07:55 PM EDT
Arcutis Biotherapeutics Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 71.33M | 88.4M | 53.64M | 96.45M | 65.08M | 63.34M | 39.39M | 3.42M |
Short-Term Investments | 156.62M | 183.46M | 355.95M | 290.61M | 219.36M | 37.93M | 11.55M | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 596K | 596K | 78K | 78K | 78K | 47K | n/a | n/a |
Receivables | 73.07M | 25.81M | 8.46M | n/a | 510K | n/a | n/a | n/a |
Inventory | 14.53M | 13.13M | 7.51M | 1.18M | -510K | n/a | n/a | n/a |
Other Current Assets | 20.27M | 9.53M | 4.46M | 1.54M | 1.54M | 1.89M | n/a | n/a |
Total Current Assets | 335.82M | 330.43M | 437.41M | 402.77M | 292.83M | 106.47M | 51.1M | 3.82M |
Property-Plant & Equipment | 2.99M | 3.9M | 4.6M | 5.3M | 5.37M | 491K | n/a | n/a |
Goodwill & Intangibles | 9.48M | 6.44M | 7.19M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 13.07M | 10.93M | 11.87M | 5.38M | 5.44M | 538K | n/a | n/a |
Total Assets | 348.89M | 341.37M | 449.27M | 408.15M | 298.27M | 107.01M | 51.1M | 3.82M |
Account Payables | 14.22M | 11.99M | 8.83M | 7.35M | 7.14M | 1.41M | 1.8M | 537K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 820K | n/a | 657K | 433K | n/a | 178K | n/a | n/a |
Other Current Liabilities | 65.15M | 19.07M | 13.67M | 15.98M | 176K | 2.1M | 116K | n/a |
Total Current Liabilities | 81.01M | 46.67M | 37.81M | 33.33M | 22.6M | 5.24M | 2.67M | 692K |
Long-Term Debt | 2.56M | 201.8M | 197.77M | 72.35M | n/a | n/a | n/a | 966K |
Other Long-Term Liabilities | 105.21M | 849K | n/a | 25K | 82K | 166.68M | 72.41M | 7.15M |
Total Long-Term Liabilities | 110.33M | 206.03M | 201.89M | 77.15M | 5.05M | 166.8M | 72.41M | 8.12M |
Total Liabilities | 191.35M | 252.7M | 239.69M | 110.47M | 27.65M | 172.04M | 75.08M | 8.81M |
Total Debt | 3.38M | 205.92M | 202.54M | 77.56M | 4.96M | 307K | n/a | 966K |
Common Stock | 12K | 9K | 6K | 5K | 4K | n/a | n/a | n/a |
Retained Earnings | -1.12B | -981.9M | -719.76M | -408.31M | -201.95M | -66.27M | -24.28M | -5.02M |
Comprehensive Income | -7K | 4K | -1.09M | -255K | -2K | -1K | n/a | n/a |
Shareholders Equity | 157.54M | 88.67M | 209.58M | 297.68M | 270.62M | -65.03M | -23.99M | -4.99M |
Total Investments | 156.62M | 183.46M | 355.95M | 290.61M | 219.36M | 37.93M | 11.55M | n/a |